2015 Trending Stocks

A Closer Look at Q3 Earnings I tell you, these numbers from the Ludwig Institute make for a pretty mixed bag. Sure, we got a slight nudge upwards in those median weekly earnings for the third quarter, like from $1,035 to $1,041. It’s a pinch of positive news, but hang on a sec before you start celebrating. The reality ain't shifting for a lot of folks, especially if...

A Tech Leap for Muskingum University Muskingum University's digital upgrade with Ellucian Student has finally arrived. It's like trading in your old clunker for a sleek, AI-powered supercar. They’ve moved their core student system to a SaaS-native environment, building on a partnership spanning nearly four decades with Ellucian. This leap isn't just about keeping up...

New Leadership at Solenis Change is brewing at Solenis, and it's set to ripple across the water treatment industry like a stone in a pond. Brendy Lange's appointment as Chief Business Officer, Americas, promises to shake things up in a firm as committed to innovation as Solenis. This seasoned executive, scooped from the ranks of Dow Chemical, steps in with a mandate to...

The Heat's On: Immersion Cooling Fluid Market Booms Kicking off with numbers straight out of the gate, data center immersion cooling fluids are gearing up for a wild ride. From just $0.23 billion back in 2026, this market is on a blitz to hit a whopping $1.06 billion by 2033. We're talking a hefty 24.8% compound annual growth rate. That's no small shakes. Race for Energy...

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Anticipation Builds Around Rocket's Earnings Call It ain't every day that a company's earnings announcement stirs up interest the way Rocket Companies' (NYSE:RKT) upcoming third-quarter results have. But here we are, just days away from October 29, 2026, when leadership will lay out the cards at 4:30 p.m. ET. This announcement might just be what investors like us need to...

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

When it comes to investment angles, nothing warms these old bones like seeing a company tie its ambitions to something weightier than bottom lines. Enter the family behind ParagonCorp, with their latest move sponsoring mental health research. Doesn't sound like your typical portfolio play, huh? But dig deeper, and you might see the layers. ParagonCorp's Commitment to...

Navigating Murky Waters: Legal Scrutiny on Shareholder Deals The financial world ain't short on drama these days, and it looks like Varonis Systems, Distribution Solutions Group, and Personalis are right in the thick of it. Each is facing scrutiny over their recent sale transactions that might not be all they’re cracked up to be. Could these deals be shortchanging...

Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...

Palantir Technologies Soars with Inclusion in the S&P 500 Palantir Technologies (NYSE: PLTR) has recently seen an impressive rise in its stock prices, thanks to its inclusion in the esteemed S&P 500 index. This news sparked excitement during premarket trading, where shares jumped by over 8%. The S&P Dow Jones Indices confirmed that Palantir will officially join the index,...

Recent Advances in GSK's Nucala for COPD GSK's phase III trial of its prominent drug Nucala (mepolizumab), aimed at treating chronic obstructive pulmonary disease (COPD), has successfully achieved its primary objective. This notable milestone in COPD treatment represents a significant step forward in therapies for respiratory conditions. The groundbreaking MATINEE study...

Understanding the Legal Landscape for Five9 Investors Faruqi & Faruqi, LLP is reaching out to investors affected by potential losses related to Five9, Inc. To ensure that victims of these circumstances are informed of their legal options, the firm's Securities Litigation Partner, James (Josh) Wilson, is available for direct consultation. He urges anyone who has purchased...

Game Changer for Quantum Technology If you thought the quantum sector was crawling, buckle up. Monarch Quantum, Inc. just landed a huge gig—delivering its integrated Quantum Light Engines™ for NASA’s upcoming Quantum Gravity Gradiometer Pathfinder mission. That’s not just a feather in their cap; it’s a serious validation of their tech chops. This isn’t just...

Jim Pazzanese Appointed to Enhance Global Procurement Strategies Buyers Edge Platform (BEP), a leader in procurement, analytics, and contract management solutions dedicated to the foodservice industry, is excited to welcome Jim Pazzanese as their new Executive Vice President of Global Strategic Procurement. With a robust background spanning over 30 years in foodservice...